Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries ADR (NY: TEVA )

16.25 -0.25 (-1.52%)
Official Closing Price Updated: 7:00 PM EDT, Jun 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Teva Pharmaceutical Industries ADR

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Analyst Ratings for Teva Pharmaceutical Indus
Via Benzinga
Tesla To Rally Around 138%? Here Are 10 Other Analyst Forecasts For Thursday
JP Morgan cut the price target for Apple Inc. (NASDAQ: AAPL) from $190 to $180. JP Morgan analyst Samik Chatterjee maintained an Overweight rating. Apple shares fell 1.1% to $133.70 in pre-market... 
Via Benzinga
Organon Stock Scores Market Leadership With Jump To 83 RS Rating
Organon sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
3 Dirt Cheap Stocks to Buy in January
Bargains can easily be found as the new year gets underway. 
Via The Motley Fool
If You Invested $1,000 in Novavax In 2020, This Is How Much You Would Have Today
The stock has gone on a wild ride over the past few years. 
Via The Motley Fool
4 Analysts Have This to Say About Teva Pharmaceutical Indus
Via Benzinga
Analyst Ratings for Teva Pharmaceutical Indus
Via Benzinga
What 4 Analyst Ratings Have To Say About Teva Pharmaceutical Indus
Via Benzinga
Most Active Equity Options For Midday - Wednesday, Jan. 11
Here are the most active equity options for midday. 
Via Talk Markets
NVAX Stock Alert: What to Know as Novavax Names New CEO
Although a change at the top boosted sentiment for Novavax, the harsh reality is that NVAX stock faces a mountain of worries. 
Via InvestorPlace
4 Stocks That Actually Increased in 2022 -- And They're Still Worth Buying Now
These all handily outperformed the market last year and could do the same in 2023. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Jazz Pharmaceuticals Files Patent Infringement Against Generic Drugmakers In New Jersey's District Court
Jazz Pharmaceuticals (NASDAQ: JAZZ), a drug company behind the CBD-based medication Epidiolex, recently filed a lawsuit against Teva Pharmaceutical Industries Ltd (NYS 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
2023 Kick-Off With Apple Losing $2T With Big Option Trades On GLD And XLE
While the tenor was more bearish, the late-day rally found the market close to where it finished 2022. 
Via Talk Markets
2 "Safe" Stocks That Are Anything But
Sometimes, business models that sound safe still fail to deliver for shareholders. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
My Top 5 Portfolio Holdings for 2023
This mix of growth and value stocks can outperform in a challenging environment. 
Via The Motley Fool
Looking At Teva Pharmaceutical Indus's Recent Unusual Options Activity
Someone with a lot of money to spend has taken a bearish stance on Teva Pharmaceutical Indus (NYSE:TEVA). And retail traders should know. We noticed this today when the big position showed up on... 
Via Benzinga
Is Prometheus Biosciences a Good Stock to Buy Right Now?
This biotech stock just jumped over 180% in a single day, and investors want to know if there could be more big gains ahead. 
Via The Motley Fool
3 Unparalleled Stocks to Buy That Have Never Been This Cheap
These three leading companies are ripe for the picking and may never be this cheap again. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Burlington Stores To Surge Over 21%? Plus Wedbush Slashes PT On Jack In The Box
Barclays raised the price target on Burlington Stores, Inc. (NYSE: BURL) from $164 to $230. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Burlington shares fell 0.1% to... 
Via Benzinga
AbbVie Finalizes To Pay Around $2.4B In Settlement Against US Opioid Lawsuits
Via Benzinga
Stocks Move Higher As Wall Street Eyes China Lockdowns
The Dow Jones Industrial Average is up 271 points midday, while the Nasdaq Composite and S&P 500 Index are firmly higher as well. 
Via Talk Markets
Why Is Imago Biosciences (IMGO) Stock Up 105% Today?
Imago Biosciences (IMGO) stock is rocketing higher on Monday following news that Merck (MRK) is acquiring the company for $36 per share. 
Via InvestorPlace
TEVA Stock Alert: What to Know About Teva Pharmaceuticals’ New CEO
Teva Pharmaceuticals (TEVA) stock is sliding on Monday after the company announced Richard Francis as its newest president and CEO. 
Via InvestorPlace
AMD To Rally Around 39%? Here Are 5 Other Price Target Changes For Monday
Baird raised Advanced Micro Devices, Inc. (NASDAQ: AMD) price target from $65 to $100. . Baird analyst Tristan Gerra upgraded the stock from Neutral to Outperform. AMD shares rose 5.7% to close at... 
Via Benzinga
Eli Lilly's Migraine Drug Infringed Teva's Patents, Ordered To Pay $176M
A federal jury has asked Eli Lilly And Company (NYSE: LLY) to pay Teva Pharmaceuticals International GmbH $176.5 million after a trial to determine whether its migraine drug Emgality infringed three... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.